Standard BioTools Inc (NASDAQ: LAB) is -40.29% lower on its value in year-to-date trading and has touched a low of $1.15 and a high of $3.04 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LAB stock was last observed hovering at around $1.17 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $1.04, the stock is -23.60% and -36.60% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.7 million and changing -10.68% at the moment leaves the stock -45.36% off its SMA200. LAB registered -56.09% loss for a year compared to 6-month loss of -51.84%.
The stock witnessed a -36.67% gain in the last 1 month and extending the period to 3 months gives it a -34.69%, and is -22.59% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.21% over the week and 7.99% over the month.
Standard BioTools Inc (LAB) has around 539 employees, a market worth around $389.01M and $174.43M in sales. Profit margin for the company is -106.00%. Distance from 52-week low is -9.52% and -65.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.09%).
with sales reaching $40.05M over the same period.The EPS is expected to grow by 65.38% this year, but quarterly earnings will post -3.74% year-over-year. Quarterly sales are estimated to shrink -12.06% in year-over-year returns.
The shares outstanding are 372.26M, and float is at 360.49M with Short Float at 3.74%.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 63.96 million shares valued at $113.21 million. The investor’s holdings represent 17.1782 of the LAB Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 58.65 million shares valued at $103.81 million to account for 15.7524 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 21.75 million shares representing 5.8424 and valued at over $38.5 million, while VANGUARD GROUP INC holds 4.2981 of the shares totaling 16.0 million with a market value of $28.33 million.
Standard BioTools Inc (LAB) Insider Activity
Still, SEC filings show that on Aug 27 ’24, Casdin Partners Master Fund, L (Director) acquired 250,000 shares at an average price of $2.19 for $0.55 million. The insider now directly holds 54,025,821 shares of Standard BioTools Inc (LAB).
